GMAB Stock Summary and Trading Ideas (Genmab A/S - American Depositary Shares | NASDAQ:GMAB)

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

What symbol and exchange does Genmab A/S - American Depositary Shares shares trade?

Genmab A/S - American Depositary Shares trades on the NASDAQ stock market under the symbol GMAB.

What is Genmab A/S - American Depositary Shares stock price doing today?

As of June 30, 2026, GMAB stock price climbed to $27.47 with 2,328,658 million shares trading.

What is Genmab A/S - American Depositary Shares's Beta?

GMAB has a beta of 0.86, meaning it tends to be less sensitive to market movements. GMAB has a correlation of 0.09 to the broad based SPY ETF.

How much is Genmab A/S - American Depositary Shares worth?

GMAB has a market cap of $16.86 billion. This is considered a Large Cap stock.

How much money does Genmab A/S - American Depositary Shares make?

Last quarter Genmab A/S - American Depositary Shares reported $896 million in Revenue and $.08 earnings per share. This fell short of revenue expectation by $-4 billion and missed earnings estimates by -$.09.

What is the highest and lowest price Genmab A/S - American Depositary Shares traded in the last 3 year period?

In the last 3 years, GMAB traded as high as $42.72 and as low as $17.24.

What are the top ETFs holding Genmab A/S - American Depositary Shares?

The top ETF exchange traded funds that GMAB belongs to (by Net Assets): IBB, FBT, AVDE, CANC, FTQI.

Is Genmab A/S - American Depositary Shares (GMAB) a good investment?

GMAB has outperformed the market in the last year with a price return of +34.0% while the SPY ETF gained +22.7%. However, in the short term, GMAB had mixed performance relative to the market. It has underperformed in the last 3 months, returning +6.4% vs +18.1% return in SPY. But in the last 2 weeks, GMAB shares have fared better than the market returning +11.8% compared to SPY -0.8%.

What are the support and resistance levels for Genmab A/S - American Depositary Shares (GMAB)?

GMAB support price is $25.48 and resistance is $26.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GMAB shares will trade within this expected range on the day.